UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $195,000 | +66.7% | 2,075 | +65.3% | 0.00% | 0.0% |
Q3 2021 | $117,000 | +9.3% | 1,255 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $107,000 | +494.4% | 1,255 | +512.2% | 0.00% | – |
Q1 2021 | $18,000 | +5.9% | 205 | 0.0% | 0.00% | – |
Q4 2020 | $17,000 | +41.7% | 205 | +32.3% | 0.00% | – |
Q3 2020 | $12,000 | -14.3% | 155 | 0.0% | 0.00% | – |
Q2 2020 | $14,000 | -17.6% | 155 | -13.9% | 0.00% | – |
Q1 2020 | $17,000 | +30.8% | 180 | +50.0% | 0.00% | – |
Q4 2019 | $13,000 | -90.7% | 120 | -91.8% | 0.00% | -100.0% |
Q3 2019 | $140,000 | +1172.7% | 1,460 | +1116.7% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 120 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | +10.0% | 120 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -9.1% | 120 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | -15.4% | 120 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | -13.3% | 120 | -20.0% | 0.00% | – |
Q1 2018 | $15,000 | +25.0% | 150 | 0.0% | 0.00% | – |
Q4 2017 | $12,000 | +9.1% | 150 | 0.0% | 0.00% | – |
Q3 2017 | $11,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q2 2017 | $11,000 | – | 150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |